Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Rekvina Laboratories Ltd. Share Price
Day's Range
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹29.22 |
|---|---|
| Day's Range | ₹29.22 - ₹29.22 |
| Open | ₹29.22 |
| 52 Week Range | ₹06.75 - ₹46.65 |
| Volume | 83 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 0.02 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 0.00 |
| TTM EPS (₹) | -0.42 |
| P/E Ratio | 0.00 |
| Book Value(₹) | -30.05 |
| PAT Margin (%) | 0.00 |
| Face Value (₹) | 5.00 |
| ROCE(%) | 0.00 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 0.0 | 0.0 |
| Expenses | N/A | N/A |
| PBT | -1.37 | -0.43 |
| Operating profit | 0.0 | 0.0 |
| Net profit | -1.37 | -0.43 |
About Rekvina Laboratories Ltd.
| Founded | 1988 |
|---|---|
| Managing Director | Amit Shah |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Adani Enterprises Ltd. | 4,07,064.39 | 3,007.00 | 1,753.00 - 1,753.00 |
| Aegis Logistics Ltd. | 48,215.12 | 1,354.00 | 576.10 - 576.10 |
| Premier Energies Ltd. | 47,483.33 | 1,046.00 | 660.00 - 660.00 |
| Aditya Infotech Ltd. | 43,676.57 | 3,687.70 | 0.00 - 0.00 |
| Redington Ltd. | 27,315.20 | 350.90 | 191.31 - 191.31 |
| Honasa Consumer Ltd. | 15,585.59 | 476.00 | 248.40 - 248.40 |
| Lloyds Enterprises Ltd. | 12,734.50 | 82.60 | 40.69 - 40.69 |
| MMTC Ltd. | 9,592.50 | 63.95 | 50.10 - 50.10 |
| SG Mart Ltd. | 9,026.64 | 710.00 | 313.10 - 313.10 |
| Cello World Ltd. | 8,261.10 | 373.00 | 336.60 - 336.60 |
No Records Found
Latest News
Rekvina Laboratories informs about updates
Rekvina Laboratories informs about board meeting
Pursuant to Regulation 29 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Rekvina Laboratories has informed that the Meeting of the Board of Directors of the Company is scheduled to be held on 21st May, 2026; 1. To consider and approve Audited Standalone Financial Results of the Company under Indian Accounting Standards (Ind AS) for the Quarter and Year ended on 31st March, 2026. 2. Any other agendas as may be considered necessary with the permission of the chair. Further, in accordance with the Company’s Code of Conduct for Prevention of Insider Trading, the Company has intimated its ‘designated persons’ regarding the closure of the Trading Window for trading in the Company’s equity shares from April 01, 2026 till the expiry of 48 hours from the date of said financial results are made public.
The above information is a part of company’s filings submitted to BSE.
Jeena Sikho Lifecare informs about change in management
Jeena Sikho Lifecare has informed about Reappointment of Mr. Karan Vir Bindra as Independent Director, Mrs. Bhavna Grover as Whole time Director and Mr. Manish Grover as Managing Director, subject to approval of shareholders.
The above information is a part of company’s filings submitted to BSE.
Munoth Communication informs about board meeting
Munoth Communication has informed that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026, inter alia, to consider and approve Unaudited Financial Results Of The Company For The First Quarter Ended June 30, 2026.
The above information is a part of company’s filings submitted to BSE.
AG Ventures - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 259.97 | 22.70 | 1045.24 | 259.97 | 22.70 | 1045.24 | 257.39 | 223.41 | 15.21 |
| Other Income | 6.78 | 4.98 | 36.14 | 6.78 | 4.98 | 36.14 | 29.37 | 17.91 | 63.99 |
| PBIDT | 245.13 | 10.01 | 2348.85 | 245.13 | 10.01 | 2348.85 | 25.00 | 64.03 | -60.96 |
| Interest | 4.96 | 0.02 | 24700.00 | 4.96 | 0.02 | 24700.00 | 10.91 | 0.09 | 12022.22 |
| PBDT | 240.17 | 9.99 | 2304.10 | 240.17 | 9.99 | 2304.10 | 14.09 | -3685.52 | -100.38 |
| Depreciation | 3.43 | 3.62 | -5.25 | 3.43 | 3.62 | -5.25 | 13.55 | 15.18 | -10.74 |
| PBT | 236.74 | 6.37 | 3616.48 | 236.74 | 6.37 | 3616.48 | 0.54 | -3700.70 | -100.01 |
| TAX | 34.03 | -19.08 | -278.35 | 34.03 | -19.08 | -278.35 | -31.43 | 38.12 | -182.45 |
| Deferred Tax | 33.46 | -20.63 | -262.19 | 33.46 | -20.63 | -262.19 | -29.78 | 19.81 | -250.33 |
| PAT | 202.71 | 25.45 | 696.50 | 202.71 | 25.45 | 696.50 | 31.97 | -3738.82 | -100.86 |
| Equity | 99.90 | 99.90 | 0.00 | 99.90 | 99.90 | 0.00 | 99.90 | 99.90 | 0.00 |
| PBIDTM(%) | 94.29 | 44.10 | 113.83 | 94.29 | 44.10 | 113.83 | 9.71 | 28.66 | -66.11 |
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Rekvina Laboratories Ltd. is ₹29.22 as of 2026-08-07.
The market capitalisation of Rekvina Laboratories Ltd. is ₹17.61 as of 2026-08-07.
The 1-year return of Rekvina Laboratories Ltd. is % as of .
The P/E ratio of Rekvina Laboratories Ltd. is 0.00 as of 2026-08-08.
The 52-week high and low of Rekvina Laboratories Ltd. are ₹46.65 and ₹6.75, respectively, as of 2026-08-07.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
